)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Rohto Pharmaceutical
Rohto Pharmaceutical (4527) investor relations material
Rohto Pharmaceutical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary12 Feb, 2026
Executive summary
Achieved double-digit sales growth across all regions, led by Asia and Europe, with consolidated sales of ¥253,071 million (+12.0% YoY), ahead of plan, driven by strong domestic and overseas demand and recent acquisitions.
Operating income rose to ¥33,575 million (+5.1% YoY), ordinary income surged 20.5% to ¥39,852 million, and profit attributable to owners of parent grew 14.3% to ¥28,279 million, supported by higher non-operating income.
Comprehensive income reached ¥33,500 million, up 29.7% year-over-year.
Full-year forecasts for sales, operating income, ordinary income, and profit attributable to owners of parent were revised upward; annual dividend increased to ¥44, marking 22 consecutive years of dividend growth.
Finalization of provisional accounting for business combinations with Eu Yan Sang International Ltd. and Mono chem-pharm Produkte GmbH, resulting in significant adjustments to goodwill and intangible assets.
Financial highlights
Q1–Q3 FY2026 sales: ¥253,071 million (+12.0% YoY); operating income: ¥33,575 million (+5.1% YoY); EBITDA: ¥46,285 million (EBITDA margin 18.3%).
Gross profit margin: 56.2%; SG&A expenses increased 12.3% YoY; profit attributable to owners of parent: ¥28,279 million (+14.3% YoY).
Full-year forecast: sales ¥340,500 million (+10.3% YoY), operating income ¥40,500 million (+5.9% YoY), ordinary income ¥46,500 million (+17.1% YoY), profit attributable to owners of parent ¥33,000 million (+7.0% YoY).
Basic earnings per share rose to ¥125.15 from ¥108.46 YoY; forecast raised to ¥146.04.
Equity-to-asset ratio improved to 62.3% from 60.2% at the previous fiscal year-end; net assets increased by ¥24,120 million to ¥304,857 million.
Outlook and guidance
Record high sales and profit expected for FY2026, despite uncertainties from inflation, cautious consumer spending, and geopolitical risks.
Upward revision of full-year forecasts for all major financial metrics; higher year-end dividend planned.
Asia and Americas expected to continue driving growth; Japan’s core business remains steady.
Upward revision driven by stronger-than-expected performance in Asia and Americas segments.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Rohto Pharmaceutical earnings date
Q4 202612 May, 2026
Rohto Pharmaceutical
Next Rohto Pharmaceutical earnings date
Q4 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Rohto Pharmaceutical Co., Ltd. is a Japanese multinational corporation specializing in health and beauty care products. The company's main business activities include the manufacture and sale of pharmaceutical products, cosmetics, and functional foods. Rohto Pharmaceutical's product range spans eye care, including eye drops and lotions; skincare, featuring dermatological preparations, lip balms, and sunscreens; and oral medications, which include digestive medicines and Chinese herbal supplements. Additionally, the company offers extracorporeal test drugs and various other health-related products. The company is headquartered in Osaka, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage